Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
Source: SeekingAlpha
2025-12-30 08:57:41 ET
Since my October article , Biogen Inc. ( BIIB ) stock has risen 18.4%, outperforming the S&P 500 [2.9% return] ( SPY ), as well as two "bellwethers" for the biotech investors, the iShares Biotechnology ETF [14%] ( IBB ) and VanEck Biotech ETF [10.1%] ( BBH )....
Read the full article on Seeking Alpha
For further details see:
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
Viatris Inc.
NASDAQ: VTRS
VTRS Trading
-3.24% G/L:
$13.735 Last:
4,592,056 Volume:
$13.77 Open:
VTRS Latest News
February 27, 2026 03:57:23 pm
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
February 26, 2026 06:55:00 am
Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend
VTRS Stock Data
$18,451,353,349
1,140,252,173
N/A
503
N/A
Pharmaceuticals
Healthcare
US
Canonsburg
